Plethico’s Natrol Acquisition Reflects Growing Indian Supplement Investment
This article was originally published in The Tan Sheet
Plethico Pharmaceuticals' $80.8 million acquisition of Natrol could be a bellwether of Indian firms' interest in growing their presence in the U.S. supplement market
You may also be interested in...
Dietary supplement industry veteran Elliott Balbert returns from semi-retirement to head Revo Biolabs, a company focused on the U.S. market with plans for segment and geographic expansion.
The dietary supplement market's attraction to pharmaceutical firms surfaces again with Sanofi-Aventis acquiring Australia's leading vitamin and mineral supplements company, Primary Health Care's Symbion Consumer business
Legitimate businesses need to think like the people adulterating products in order to anticipate scenarios that would lead to another unknown contaminant like melamine entering the food supply, experts agree